Company intelligence / Profile preview

First Island Capital

Mercer Island, Washington, United States

Ownership: Private
Development stage: Other

Overview

First Island Capital is a private investment firm and broker-dealer based in Mercer Island, Washington, that specializes in the biotechnology and life sciences sectors. The firm is recognized for its active participation in premier industry events, including the BIO CEO & Investor Conference, where it conducts buy-side research to identify high-potential therapeutic developments. Founded in 1994, First Island Capital provides strategic capital and investment services to both emerging and established healthcare companies. By focusing on innovative clinical programs and molecular diagnostics, the firm plays a role in supporting the commercialization of next-generation medical treatments.

Industry: Investors

Partnerships

Biotechnology Innovation Organization (BIO)

Beyond the preview

Go deeper on First Island Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Island Capital.

Explore the full profile